Reuters logo
FDA lifts hold on Concert Pharma's hair loss drug
July 10, 2017 / 11:42 AM / in 5 months

FDA lifts hold on Concert Pharma's hair loss drug

July 10 (Reuters) - Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration lifted the clinical hold on a mid-stage study testing its drug to treat alopecia areata, a type of hair loss.

The company, which will resume enrollment later this month, expects to complete the study in the second half of 2018. (Reporting by Divya Grover in Bengaluru; Edited by Martina D‘Couto)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below